Cerebral Autoregulation Monitoring to Reduce Brain Injury from Cardiac Surgery
Cerebral Autoregulation Monitoring to Reduce Brain Injury from Cardiac Surgery
批准号:
8909159
负责人:
CHARLES W HOGUE
金额:
$38.54万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-01 至 2016-06-30
关键词:
Acute Renal Failure with Renal Papillary NecrosisAgeBlood Flow VelocityBlood PressureBlood VesselsBlood flowBrainBrain InjuriesCardiacCardiac Surgery proceduresCardiopulmonary BypassCaringCerebral EmboliCerebrovascular CirculationCerebrumCharacteristicsClinicalCognitiveComplicationComputer softwareCoronary Artery BypassDataDeliriumDiabetes MellitusDiagnosisDiffusion Magnetic Resonance ImagingDistalEarly DiagnosisEnsureExpenditureFrequenciesGenderGoalsHealth Care CostsHealthcareHomeostasisHospitalizationHypertensionHypotensionImaging TechniquesImpaired cognitionImpairmentIndividualLeadLesionLinear RegressionsMagnetic Resonance AngiographyMagnetic Resonance ImagingMeasuresMetabolicMethodsMissionMonitorMorbidity - disease rateNational Heart, Lung, and Blood InstituteNear-Infrared SpectroscopyNeurologicNeurological outcomeOperative Surgical ProceduresOrganOutcomeOxygen saturation measurementPatientsPerioperativePostoperative PeriodPublic HealthQuality of lifeRandomizedRiskSignal TransductionSourceStenosisStrokeStructureTechniquesTimeTransient Ischemic AttackVascular Diseasesadverse outcomeagedbaseblood pressure reductionblood pressure regulationcerebral hypoperfusionclinical investigationcognitive testingexhaustfollow-uphigh riskindexingmortalitynovelpressurepublic health relevancetime use
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Brain injury during cardiac surgery results primarily from cerebral embolism and/or reduced cerebral blood flow (CBF). The latter is of particular concern for the growing number of surgical patients who are aged and/or who have cerebral vascular disease. Normally, CBF is physiologically autoregulated (or kept constant) within a range of blood pressures, allowing for stable cerebral O2 supply commensurate with metabolic demands. Cerebral autoregulation is impaired in patients who are undergoing cardiac surgery and have cerebral vascular disease or many other conditions. Such impairment could lead to brain injury because current practices of targeting low mean arterial blood pressure empirically (usually 50-70 mmHg) during cardiopulmonary bypass (CPB) may expose patients with impaired cerebral autoregulation to cerebral hypoperfusion. The hypothesis of this study is that targeting mean arterial pressure during CPB to a level above an individual's lower autoregulatory threshold reduces the risk for early neurologic complications from cardiac surgery or postoperative cognitive decline. Cerebral autoregulation will be monitored in real time by using software that continuously compares the relation between arterial blood pressure and low-frequency changes in transcranial Doppler measured cerebral blood flow velocity as well as cerebral oximetry measured with near infrared spectroscopy using methods we have validated. The primary endpoint of the study will be a composite outcome of clinical stroke, and/or new ischemic brain lesions detected with diffusion-weighted magnetic resonance (MR) imaging, and/or cognitive decline from baseline at 4 to 6 weeks after surgery. We will further assess for a relationship between blood pressure below the limits of autoregulation and delirium, an end-point associated with morbidity and mortality. Brain injury from cardiac surgery is an important source of operative mortality, prolonged hospitalization, increased healthcare expenditure, and impaired quality of life. Developing strategies to reduce the burden of this complication has wide public health implications and is within the mission of the NHLBI.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CEREBRAL AUTOREGULATION MONITORING TO REDUCE BRAIN INJURY FROM CARDIAC SURGERY
-
批准号:9315210
-
项目类别:
-
资助金额:$35.3万
-
财政年份:2016
-
负责人:CHARLES W HOGUE
-
依托单位:
CEREBRAL AUTOREGULATION MONITORING TO REDUCE BRAIN INJURY FROM CARDIAC SURGERY
-
批准号:9306643
-
项目类别:
-
资助金额:$39.41万
-
财政年份:2016
-
负责人:CHARLES W HOGUE
-
依托单位:
Continuous Cerebral Autoregulation Monitoring to Reduce Brain Injury from Cardiac
-
批准号:8123192
-
项目类别:
-
资助金额:$31.62万
-
财政年份:2009
-
负责人:CHARLES W HOGUE
-
依托单位:
Cerebral Autoregulation Monitoring to Reduce Brain Injury from Cardiac Surgery
-
批准号:8293199
-
项目类别:
-
资助金额:$32.3万
-
财政年份:2009
-
负责人:CHARLES W HOGUE
-
依托单位:
Cerebral Autoregulation Monitoring to Reduce Brain Injury from Cardiac Surgery
-
批准号:8510708
-
项目类别:
-
资助金额:$31.06万
-
财政年份:2009
-
负责人:CHARLES W HOGUE
-
依托单位:
Cerebral Autoregulation Monitoring to Reduce Brain Injury from Cardiac Surgery
-
批准号:8757012
-
项目类别:
-
资助金额:$31.65万
-
财政年份:2009
-
负责人:CHARLES W HOGUE
-
依托单位:
Continuous Cerebral Autoregulation Monitoring to Reduce Brain Injury from Cardiac
-
批准号:7920211
-
项目类别:
-
资助金额:$31.94万
-
财政年份:2009
-
负责人:CHARLES W HOGUE
-
依托单位:
Continuous Cerebral Autoregulation Monitoring to Reduce Brain Injury from Cardiac
-
批准号:7714660
-
项目类别:
-
资助金额:$31.17万
-
财政年份:2009
-
负责人:CHARLES W HOGUE
-
依托单位:
Estradiol For Neurocognitive Dysfunction After CABG
-
批准号:7223372
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2001
-
负责人:CHARLES W HOGUE
-
依托单位:
Estradiol For Neurocognitive Dysfunction After CABG
-
批准号:6537761
-
项目类别:
-
资助金额:$54.1万
-
财政年份:2001
-
负责人:CHARLES W HOGUE
-
依托单位:
Estradiol For Neurocognitive Dysfunction After CABG
-
批准号:6638608
-
项目类别:
-
资助金额:$54.98万
-
财政年份:2001
-
负责人:CHARLES W HOGUE
-
依托单位:
Estradiol For Neurocognitive Dysfunction After CABG
-
批准号:6325072
-
项目类别:
-
资助金额:$50.42万
-
财政年份:2001
-
负责人:CHARLES W HOGUE
-
依托单位:
Estradiol For Neurocognitive Dysfunction After CABG
-
批准号:6748602
-
项目类别:
-
资助金额:$55.89万
-
财政年份:2001
-
负责人:CHARLES W HOGUE
-
依托单位:
Estradiol For Neurocognitive Dysfunction After CABG
-
批准号:6891874
-
项目类别:
-
资助金额:$7.89万
-
财政年份:2001
-
负责人:CHARLES W HOGUE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: